Kyverna Therapeutics, Inc. beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.67 | $-0.63 | +6.0% | Beat |
| Q12026 FY2026 | $-0.75 | $-0.66 | +12.0% | Beat |
| Q42025 FY2025 | $-0.80 | $-0.80 | +0.0% | Beat |
Back to KYTX overview · KYTX holders · KYTX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.